How Lion's Mane Stimulates Nerve Growth Factor — and Why That Matters

12 hours ago
5 min read

Nerve Growth Factor (NGF) is a protein the brain requires to maintain and repair neurons throughout life. Its levels decline with age, and that decline is causally implicated in Alzheimer's disease, Parkinson's disease, and age-related memory loss. Lion's mane is the only widely consumed food known to contain compounds that directly stimulate NGF synthesis inside the central nervous system. The mechanism has been characterized to the molecular level: two classes of terpenoids, hericenones and erinacines, cross the blood-brain barrier and induce NGF production in the cells that surround and support neurons.

What Nerve Growth Factor does and why its decline matters

NGF is a member of the neurotrophin family — proteins that regulate the growth, maintenance, and survival of specific neurons. In the peripheral nervous system, NGF is essential to sensory and sympathetic neurons. In the central nervous system, it is critical to the cholinergic neurons of the basal forebrain — the precise population of cells whose degeneration is the defining pathological feature of Alzheimer's disease.

NGF does more than support cell survival. It regulates synaptic plasticity — the brain's capacity to strengthen or weaken connections between neurons in response to experience, which is the cellular basis of learning and memory. When NGF is adequate, neurons form connections, repair damage, and maintain function. When NGF declines, as it measurably does with age, neurons atrophy and eventually die. The loss is not evenly distributed: the memory-critical hippocampus and the attention-regulating prefrontal cortex are disproportionately affected. This anatomical specificity explains why age-related cognitive decline follows predictable patterns — memory and executive function deteriorate before other domains.

NGF deficiency has been a therapeutic target in neurodegeneration research for decades. The challenge has always been delivery. NGF as a protein cannot cross the blood-brain barrier. Clinical trials of direct NGF infusion required neurosurgical implants and produced serious side effects. Small-molecule compounds that stimulate the body's own NGF production represent a fundamentally different and far more accessible approach — and that is precisely what lion's mane contains.

How hericenones and erinacines were discovered

The discovery of NGF-stimulating compounds in lion's mane began in the early 1990s. Japanese researchers isolating bioactive compounds from Hericium erinaceum identified a series of diterpenoid molecules — erinacines A, B, and C — from the fungal mycelium. These compounds were found to strongly promote NGF synthesis in astroglial cells, the support cells that surround and nourish neurons. The finding was significant enough that it redirected years of subsequent research toward the neurological applications of this mushroom.

Subsequent research identified hericenones — a structurally distinct class of compounds isolated from the mushroom's fruiting body rather than its mycelium. Hericenones are cytoprotective: they protect neurons from cell death induced by ER stress and oxidative damage, complementing the NGF-stimulating activity of erinacines. Together, the two classes create a dual mechanism: erinacines promote the growth and maintenance of new neurons; hericenones help protect existing neurons from death. In practical terms, lion's mane works on both the supply side and the protection side of neuronal health simultaneously.

Erinacines A, B, and C, isolated from the mycelia of Hericium erinaceum, were identified as strong stimulators of nerve growth factor synthesis, promoting NGF production in astroglial cells. These diterpenoid compounds represent the primary neurotrophin-stimulating mechanism of the mushroom. Kawagishi et al., Tetrahedron Letters, 1994.

The blood-brain barrier problem and how lion's mane solves it

The blood-brain barrier is a selective membrane that separates circulating blood from the central nervous system. It allows small molecules, gases, and lipid-soluble compounds to cross while blocking larger proteins and most water-soluble compounds. NGF itself, as a protein, cannot cross this barrier. That is why direct NGF supplementation has never become clinically practical despite decades of research interest.

Erinacines are small enough and lipophilic enough to cross. Animal studies have confirmed that erinacine A and erinacine S, when administered orally, reach brain tissue and stimulate endogenous NGF production in the central nervous system. This is not peripheral stimulation with indirect effects — it is direct stimulation inside the brain. The practical consequence is that oral consumption of lion's mane, in food or supplemental form, can elevate CNS NGF levels through a non-invasive dietary route. No other widely available food has this property.

Erinacine A and erinacine S derived from Hericium erinaceus mycelium were demonstrated to cross the blood-brain barrier in rat models, stimulating NGF synthesis in central nervous system tissue following oral administration. Tsai et al., 2021, as cited in Contato and Conte-Junior, Nutrients, 2025.

What this mechanism means clinically

The NGF-stimulating mechanism directly explains the clinical trial outcomes observed in human studies. The foundational 2009 Mori trial found that cognitive scores rose progressively over 16 weeks of lion's mane supplementation and declined again after discontinuation — a washout pattern consistent with progressive NGF-supported neuronal maintenance that reverses when the stimulus is removed.

The most rigorously designed human trial to date examined the specific NGF mechanism directly. In a 49-week study of 49 patients with mild Alzheimer's disease, participants receiving erinacine A-enriched lion's mane mycelium showed not only significantly less cognitive deterioration than placebo but also measurably higher plasma NGF levels at end of treatment. The elevated NGF in the treatment group provides direct biological confirmation that the proposed mechanism — oral lion's mane consumption raising NGF in humans — operates as hypothesized.

In a double-blind placebo-controlled pilot trial of 49 patients with mild Alzheimer's disease, 49 weeks of erinacine A-enriched Hericium erinaceus mycelia supplementation resulted in significantly lower cognitive deterioration and measurably higher plasma NGF levels in the treatment group compared to placebo, providing direct human evidence for the NGF-stimulating mechanism of lion's mane. Li et al., Frontiers in Aging Neuroscience, 2020.

A 2025 narrative review confirmed that the capacity of Hericium erinaceus to stimulate NGF synthesis is the primary mechanism underlying its neuroprotective properties, supported by both in vitro, preclinical, and human clinical data. The review identified the NGF pathway as the central pharmacological mechanism distinguishing lion's mane from other medicinal fungi. Contato and Conte-Junior, Nutrients, 2025.

A systematic review of 26 human and preclinical studies confirmed the neuroprotective effects of Hericium erinaceus, identifying NGF stimulation alongside antioxidant, anti-inflammatory, and anti-tumor mechanisms. The review noted the mushroom's potential as a functional food and adjunct therapeutic agent in neurodegenerative disease, pending larger clinical trials. Menon et al., Frontiers in Nutrition, 2025.

What this means for your plate

The NGF mechanism is why lion's mane is categorically different from other functional foods. Most health-promoting foods work through broad antioxidant or anti-inflammatory effects. Lion's mane acts on a specific molecular pathway whose role in brain aging and neurodegeneration is well established. You are not eating something that is generally good for you and hoping it helps your brain. You are eating the only food that contains compounds demonstrated to directly stimulate the protein your brain uses to maintain its neurons.

Hericenones, the fruiting body compounds, are present in fresh lion's mane exactly as consumed. No extraction or processing required. The clinical trial evidence for the NGF mechanism was built, in large part, on whole mushroom preparations. Fresh lion's mane two to three times per week delivers the relevant bioactive compounds through the same dietary route the research validated.

Continue exploring the Lion's Mane science

What Are the Proven Health Benefits of Lion's Mane Mushroom?
Can Lion's Mane Improve Memory and Focus? What the Clinical Trials Show
Does Lion's Mane Help with Anxiety and Depression?
What Does the Research Say About Lion's Mane and Alzheimer's Disease?